The 3+3 versus model-based approach: implementation in the CAPCISUM pancreatic cancer trial

by Qian, Wendi, Mander, Adrian, Machin, Andrea, Dalchau, Katy, Corrie, Pippa
Published 2015

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 ran...

by Stark, Dan, Nankivell, Matthew, Pujade-Lauraine, Eric, Kristensen, Gunnar, Elit, Lorraine, Stockler, Martin, Hilpert, Felix, Cervantes, Andrés, Brown, Julia, Lanceley, Anne, Velikova, Galina, Sabate, Eduardo, Pfisterer, Jacobus, Carey, Mark S, Beale, Philip, Qian, Wendi, Swart, Ann Marie, Oza, Amit, Perren, Tim
Published 2013

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective...

by Parkinson, Christine A., Gale, Davina, Piskorz, Anna M., Biggs, Heather, Hodgkin, Charlotte, Addley, Helen, Freeman, Sue, Moyle, Penelope, Sala, Evis, Sayal, Karen, Hosking, Karen, Gounaris, Ioannis, Jimenez-Linan, Mercedes, Earl, Helena M., Qian, Wendi, Rosenfeld, Nitzan, Brenton, James D.
Published 2016

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

by S. Ahmad, Saif, Qian, Wendi, Ellis, Sarah, Mason, Elaine, Khattak, Muhammad A., Gupta, Avinash, Shaw, Heather, Quinton, Amy, Kovarikova, Jarmila, Thillai, Kiruthikah, Rao, Ankit, Board, Ruth, Nobes, Jenny, Dalgleish, Angus, Grumett, Simon, Maraveyas, Anthony, Danson, Sarah, Talbot, Toby, Harries, Mark, Marples, Maria, Plummer, Ruth, Kumar, Satish, Nathan, Paul, Middleton, Mark R., Larkin, James, Lorigan, Paul, Wheater, Matthew, Ottensmeier, Christian H., Corrie, Pippa G.
Published 2015